Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRD205 for postoperative pain after hip replacement (phase IIb)
CTR20260392Phase 2Active
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd.
- Start
- Mar 2026
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TRD205 in postoperative pain, sponsored by Beijing Tide Pharmaceutical Co., Ltd.. Started Mar 2026; status: active.
02
Drugs
TRD205
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20260392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260392.